Event content

Rapid and efficient development of drug candidates is increasingly important for pharmaceutical companies with accelerated timelines and funding constraints. However, many early drug candidates have poor oral absorption properties making it challenging to achieve target pharmacokinetic (PK) profiles. Witho...

In pharma, it is essential to identify the right partner to ensure a successful outcome. Time and time again, mistakes have been made in this process, causing clinical studies to fail and for the company to take a heavy hit. Want to avoid this? join our one-hour masterclass where we will devise a checklist...

Get the inside focus on the latest drug pricing developments in the US market. Listen to the current legislator updates and how it will affect patient costs while reviewing the rising manufacturing costs from inflation and supply constraints and the market’s reaction: • Examining current manufacture ...

M&A plays a pivotal role in pharma growth as it enables companies to streamline their operations and strategies while reducing overhead costs, which can contribute to profit growth. To understand more, join our informative session, where our market experts will highlight and discuss the latest trends in th...

Transitioning drugs from IV to subcutaneous (SC) delivery brings new requirements and impacts program considerations for combination product development. In this session, we identify trade-offs that pharma weighs to de-risk combination product development programs involving large volume subcutaneous (LVSC...

Packaging is an integral part of the design for pharmaceutical products and medical devices. Not only does one need to take into account the look, feel, and protective qualities of the packaging but design must be considered when determining the sterilization technology. Determining the sterilization techn...

Connecting medication and medical devices to the internet can enhance product protection, improve patient safety and outcomes, and optimize processes along complex supply chains. NFC-RFID technologies are increasingly used to provide connectivity benefits more securely and efficiently, ensuring that pharma...

The presentation will look in some detail how aging / stability studies are established and address the following • What is aging / stability? • What is purpose of aging / stability testing? • What about relative humidity? • What risks are involved? • How long is the shelf life of your prod...

This short session answers the most pressuring strategic questions with regards to sustainability: Why does it matter? Where to focus? How is it measured? What is the current industry status? How to improve?

Did you enjoy this session? If so, you might like to visit our Connect to Frankfurt plat...

Polysorbates are intensively used in biologics formulation as stabilizer due to their propensity to inhibit aggregation at interfaces but possess low intrinsic stability. In this study, the chemical stability of KLEPTOSE® HPBCDs are compared with polysorbates under various stress conditions.

Wh...

Healthcare supply chains are under constant pressures, whether its political complexities, the unexpected in everyday operations, and, most recently, a worldwide inflation spiral.

Companies can use these pivotal pressures to build a competitive edge. Now is the time to optimize your supply chain...

Pfizer’s manufacturing excellence story can be likened to the sport of crew rowing. Eight people, literally rowing in the same direction in unison. Multiple efforts, focus and strengths are combined in the pursuit of a common goal. It takes precise choreography, teamwork and a common understanding of the m...

In this webinar, originally broadcast as part of the Pharmapack Europe show, Elina Iamsia and Klaus Heinisch from Edelmann Group, one of the leading manufacturers of paper-based packaging, discusses a range of perspectives on sustainability in packaging. They deep dive into a framework designed to illustra...

In this webinar, originally broadcast as part of the Pharmapack Europe show, Corinne Ondo, Head of Sourcing Production Materials Biotech & Healthcare Innovation, Merck discusses how Healthcare is currently improving packaging reuse in its supply chain by working in close partnership with its suppliers. By...

In this webinar, originally broadcast as part of the Pharmapack Europe show, Katsuyuki Takeuchi, Associate Product Manager, Terumo Europe NV will discuss how the world, and in particular the world of Plastics needs to change its Consumption, Production and Value Creation practices. Global Challenges such a...

In this webinar, originally part of Pharmapack Europe 2022, S. Ross Tsakas, Pharmaceutical Segment Leader, Sterigenics discusses parenteral drug development. Parenteral drugs and the drug development lifecycle represent complexities across the multi-year, multi-million pledges made. With over 90 years of e...

CDMO’s accelerating adoption Reshoring: CM can help when competing with Asian producers on price. Government investment during Covid to protect against supply chain issues & increased focus on critical drugs supply New guidance based on GMP - ICH Q13 will likely see smaller companies deciding to ...

As clients seek to gain maximum benefit from each clinical stage, the advantages offered by contract partners with integrated services are making these higher returns tangible. This presentation will highlight key activities under Thermo Fisher’s integrated drug substance and product development services f...

Recent Congressional proposals have been targeted at drug pricing reform, including opportunities to allow Medicare to negotiate prices for certain drug products, penalizing prices that rise faster than the rate of inflation, and capping out-of-pocket costs for beneficiaries in the Medicare Part D program....

Talk of bringing back domestic manufacturing to North America has dominated conversations around pharma manufacturing for years, and have been a key talking point in government post-pandemic recovery plans, but how far have we come and who is this really working for? Asian CDMO’s recognizing the trend f...